Tag: "launched" at medical news

IMA wants members not to do sex determination tests during pregnancy

...ional president, said an awareness drive should be launched to prevent female foeticide and infanticide. Mr. L. K. Tripathy, Health Secretary, pointed to three indicators in the census 2001 and said the situation in the State had improved compared to the previous decade. Ms. Sabitha Naqvi, from UNICEF, New...

Glaxo launches pills to help smokers quit in 7-12 weeks

GLAXO SmithKline India has launched an oral treatment for smoking, called Zyban. The pill (generic - Bupropion Hydrochloride) is reportedly the first product aimed at stopping smoking and is available at Rs. 40 per tablet. Speaking to newspersons, Mr. Kalyanasundaram, Director (Pharm...

E Merck introduces Livogen Z with zinc sulphate

E Merck has launched Livogen Z, in the market with zinc sulphate.Livogen Z is one of the three versions of the trademark haematinic drug Livogen.Livogen was an old product of Glaxo India with Rs 3 crore revenue.Glaxo India Ltd has sold its Livogen brand to E Merck India ...

'Prozac miracle' could end in disaster

A major lawsuit has been launched against the British pharmaceutical giant GlaxoSmithKline on behalf of a group of people who say they became chronically addicted to an antidepressant drug in the same class as Prozac. The case, which has been filed in California, is the first ever to...

Emphysema surgery - unbeneficial

...d enormously and the National Institutes of Health launched further trials to see if the operation was really effective. People had either surgery or standard medical management for their condition. The first report of the trial now urges caution over surgery. The sickest patients - those with the worst lung ...

NPIL withdraws Parkinson’s dru

...ips came under the price control which the company launched after the price control on vials.// The existing MRP of a 10 tablet strip of 250 mg was Rs 56, whereas the company was seeking an MRP of Rs 97.84 to make it viable for the company....

Ajanta Launches World's First Once-A-Day Nimesulide Oral Formulation

The Mumbai-based Ajanta Pharmaceuticals (APL) has launched its once-a-day 200mg controlled release nimesulide brand Nimlodi for arthritis. Nimlodi, which was developed by the Company through new drug delivery system, is the world's first once-a-day nimesulide brand for the treatment of arthritis. Ajanta, whi...

'Disprin Plus' is now 'Disprin Paracetamol'

...Baura said. Paracetamol-based Disprin 'Plus' was launched by Reckitt Benckiser (India) in August this year t...Barua said Disprin CV (100 mg aspirin) will not be launched till the new brand 'Disprin Paracetamol' is completely established....

A new treatment for liver cancer

...e liver cancer. It is a year since TheraSphere was launched at the University of Texas and it is showing a 25 per cent success rate in either reducing tumour size or the number of tumours. Till date, it has many patients have undergone this treatment with advanced liver tumours, who cannot ...

Risk Of Developing Arthritis

...ht regret it later,” Logan says. The charity has launched a campaign to raise ￡ 250,000 to fund its sports injuries-related work. The charity is currently financing work into a new type of cartilage transplant surgery aimed specifically at younger people with sports injuries. It is also funding extensive wo...

ZYDUS enters female health care segment

...ed, the Ahmedabad based pharmaceutical company has launched a revolutionary drug, Bonmax (raloxifene hydrochloride) consolidating its presence in the female healthcare segment. Bonmax is used in the prevention and treatment of postmenopausal osteoporosis (PMO). The drug comes as third generation drug which no...

Dr Reddy’s Laboratories launches Hyalosy

The Hyderabad-based Dr Reddy’s Laboratories has launched Hyalosyn (sodium hyaluronate), an intra-articular ...20 mg/2ml of sodium hyaluronate. Hyalosyn is being launched under a co-marketing arrangement with Gland Pharma, a pharmaceutical company in Hyderabad well known...

Sun Pharma to launch chiral version of omeprazole soon

...sion that goes by the brand name ‘Nexium’ which it launched in March 2001 in the regulated markets. The anti-ulcerant market in India is estimated to be over Rs 444.63 crore growing at 14.6 per cent with about 10 to 15 major firms competing. Analysts are optimistic of the launch and said that this would bri...

Influenza drug delayed

...amiflu Oral Suspension product, was supposed to be launched this season. Hoffmann-La Roche informed the FDA of its production problems, but FDA spokeswoman Sharon Jayne said the company was not required to do so. // Tamiflu is one of two FDA approved drugs in a new class of medications, which attack the viru...

Hope for tinnitus sufferers

...s, is chronic and debilitating.// Researchers have launched a full-scale trial of a promising study suggesting that differentiating between computer-generated tones could help relieve the problem. Unlike people without the condition, those with tinnitus have a disproportionately large region of their brain w...

Loss of weight

...lions of patients have taken the drug since it was launched in 1997....

A new herbal therapy to quit smoking

...wtrition Remedies, a herbal medicine manufacturer, launched its "Quit Smoking Programme". Known as the "Trans-Alpha-Herbal Therapy", //the programme will focus on assisting smokers overcome physical and psychological addiction to tobacco and will begin with an attempt to de-automise the habit. This will turn ...

Apollo inaugurates centre for back and neck pain

Apollo Hospitals recently launched a one crore documentation based care (DBC) centre project in Chennai for back and neck pain management, claimed to be the first of its kind in the country. Dr Pratap Reddy, //chairman of Apollo Hospitals told the press that DBC, a revolutionary conce...

Emphysema surgery - unfavourable

...d enormously and the National Institutes of Health launched further trials to see if the operation was really effective. People had either surgery or standard medical management for their condition. The first report of the trial now urges caution over surgery. The sickest patients - those with the worst lung ...

Canine Painkiller unveiled by Novartis

...cilities. The marketing campaign for the drug was launched in late September and veterinarian offices were the primary focus. Novartis expects to spend $25 million to market Deramaxx with a goal of reaching every veterinarian in the country in the first year. The company is banking on pet owner appeal to mak...

1 2 3 4 5 6 7 8 9 10